A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
for Multiple Sclerosis
1 location in Wilmington
Sponsor: TG Therapeutics, Inc.
Sex: Female·Age: 15 - 50
Code: NCT06433765·Recruiting·Listed May 2024